A single-institution retrospective study of multicentric gliomas stratified by IDH mutational status
Neuro-Oncology Advances · 12.01.2026 · 8 (1)
DOI: 10.1093/noajnl/vdag047 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neuro-Oncology Advances, online erschienen am 10.05.2026. Verfasst von Chuyin Yang und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, University of California, Los Angeles, Los Angeles, California, USA. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, Bradley Zankel Foundation and National Institutes of Health (NIH)/National Cancer Institute, NIH/NCI.
Abstract (Originalsprache)
Background
Multicentric glioma (MCG) are defined radiographically as two or more tumor foci with separation of MRI T2-FLAIR (T2-weighted Fluid-attenuated Inversion Recovery) hyperintensities presenting synchronously (sMCG) and/or metachronously (mMCG). Previous studies have not stratified isocitrate dehydrogenase (IDH) wild-type and mutant gliomas by sMCG and mMCG. In this large, single-institution cohort stratified by IDH status, we evaluated MCG prevalence, prognostic implications, time to mMCG (TtM), location, and pathological concordance.
Methods
We identified 836 IDH wild-type and 531 IDH mutant diffuse glioma patients treated at our institution with evaluable MRI. We inspected MRIs at presentation for sMCG and subsequent imaging for mMCG, reviewed radiology and pathology reports, and performed overall survival (OS) and TtM analyses.
Results
MCG prevalence was higher in IDH wild-type cases (18%) than in IDH mutant cases (9%) (P < .0001). We found 20 sMCG and 26 mMCG in IDH mutant and 91 sMCG and 54 mMCG in IDH wild-type patients. In 7 wild-type and 1 mutant instances, mMCG arose from sMCG (smMCG). While sMCG and mMCG were associated with lower OS in IDH wild-type cases (sMCG: HR = 1.46, P = .003; mMCG: HR = 1.44, P = .02), only mMCG was associated with lower OS in IDH mutant cases (sMCG: HR = 1.22, P = .7; mMCG: HR = 2.64, P = .001). IDH wild-type cases had shorter TtM than mutant cases (P < .0001). Among double-biopsied MCG, pathology discordance occurred in 5/7 mutant but 0/28 wild-type cases.
Conclusion
Results from this cohort of diffuse gliomas stratified by IDH status showed differences between IDH wild-type and mutant cohorts in prevalence, prognosis, TtM, distribution, and pathological concordance.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurology, University of California, Los Angeles, Los Angeles, California, USA.
- Department of Neurosurgery, University of California, Los Angeles, Los Angeles, California, USA.
- Department of Radiology, University of California, Los Angeles, Los Angeles, California, USA.
ORCID-Profile: Albert Lai
Förderung
- NCI NIH HHS
- Bradley Zankel Foundation and National Institutes of Health (NIH)/National Cancer Institute
- NIH/NCI
- Department of Defense (DoD) CDMRP
- Sontag Foundation
- the National Brain Tumor Society
Zitieren
APA
Yang, C., Mostafavi, R., Le, C., Fisher, A., Eldred, B. S. C., Prins, T. J., Lai, T. J., Liau, L. M., Everson, R. G., Chong, R. A., Nghiemphu, P. L., Cloughesy, T. F., Ellingson, B. M., & Lai, A. (2026). A single-institution retrospective study of multicentric gliomas stratified by IDH mutational status. Neuro-Oncology Advances, 8(1). https://doi.org/10.1093/noajnl/vdag047
Vancouver
Yang C, Mostafavi R, Le C, Fisher A, Eldred BSC, Prins TJ, et al. A single-institution retrospective study of multicentric gliomas stratified by IDH mutational status. Neuro-Oncology Advances. 2026;8(1). doi:10.1093/noajnl/vdag047
BibTeX
@article{Yang2026,
author = {Yang, Chuyin and Mostafavi, Ryan and Le, Collin and Fisher, Addison and Eldred, Blaine S C and Prins, Terry J and Lai, Thomas J and Liau, Linda M and Everson, Richard G and Chong, Robert A and Nghiemphu, Phioanh L and Cloughesy, Timothy F and Ellingson, Benjamin M and Lai, Albert},
title = {A single-institution retrospective study of multicentric gliomas stratified by IDH mutational status},
journal = {Neuro-Oncology Advances},
year = {2026},
volume = {8},
number = {1},
doi = {10.1093/noajnl/vdag047}
}
EUVIMED